实例探究 > Global Biopharmaceutical Company Engages HCPs More Effectively with Compliant Email

Global Biopharmaceutical Company Engages HCPs More Effectively with Compliant Email

公司规模
1,000+
地区
  • America
  • Europe
  • Pacific
国家
  • Australia
  • European Union
  • United States
产品
  • Veeva CRM Approved Email
  • Veeva CRM
  • Veeva CLM
  • Veeva Vault PromoMats
  • Veeva CRM Engage Meeting
技术栈
  • Email Marketing
  • CRM
  • Digital Asset Management
  • Web Conferencing
实施规模
  • Enterprise-wide Deployment
影响指标
  • Brand Awareness
  • Customer Satisfaction
  • Productivity Improvements
技术
  • 应用基础设施与中间件 - 数据交换与集成
  • 功能应用 - 企业资产管理系统 (EAM)
  • 功能应用 - 企业资源规划系统 (ERP)
适用行业
  • 医疗保健和医院
  • 药品
适用功能
  • 商业运营
  • 销售与市场营销
用例
  • 质量预测分析
  • 监管合规监控
服务
  • 云规划/设计/实施服务
  • 数据科学服务
  • 系统集成
关于客户
The customer is a global biopharmaceutical company with a focus on serving high unmet medical needs. The company is an industry leader and was preparing for two blockbuster drug launches. The company's field teams consist of representatives and medical science liaisons (MSLs) who interact with healthcare professionals (HCPs) to educate them about new products. The company needed a solution that would allow their field teams to send personalized, compliant emails to HCPs to supplement face-to-face interactions and provide valuable scientific information outside of office visits.
挑战
With two blockbuster drug launches on the horizon, a global biopharmaceutical company sought a new way to reach healthcare professionals (HCPs) to supplement face-to-face interactions and educate about new products. Giving field teams the ability to send personalized email to customers would increase engagement and deliver valuable scientific information outside of office visits. At the same time, the company had to ensure its teams only sent approved, compliant content to HCPs. They needed an email solution that was built for life sciences.
解决方案
The company chose Veeva CRM Approved Email to extend face-to-face conversations with HCPs and deliver personalized content that drives awareness throughout product launches. The solution lets reps and medical science liaisons (MSLs) email customers using only content that has passed medical, legal, and regulatory (MLR) review. Field teams can easily send compliant emails from the system where they work every day: Veeva CRM. The company also uses Veeva Vault PromoMats, which combines digital asset management (DAM) capabilities with MLR review in a single enterprise cloud application. This allows the company to streamline processes and move faster, updating templates based on customer preferences and making them available through Veeva CRM Approved Email within 24 hours.
运营影响
  • Provided 300 reps with compliant email capabilities for two blockbuster drug launches.
  • Quickly responded to business needs and customer preferences by delivering updated email templates within 24 hours.
  • Enhanced brand, medical, and sales collaboration with one system for email content management, distribution, and analysis.
  • Reps did not need to learn a new email system before the launches due to their familiarity with Veeva CRM.
  • Managing email templates is easy for the organization. Veeva CRM Approved Email includes a multichannel repository that manages content across all Veeva CRM channels, providing a single source of compliant materials.
数量效益
  • Achieved email open rates of 60%—3x higher than industry average.
  • Increased interaction with customers by 30%.

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

相关案例.

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。